Veradigm (MDRX) – Company Press Releases
-
Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings
-
Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
-
Veradigm Announces Initial Financial Guidance for Fiscal 2024
-
Veradigm Completes Acquisition of ScienceIO
-
Veradigm to Participate in Barclays 26th Annual Global Healthcare Conference
-
Sprinklr Set to Join S&P SmallCap 600
-
Veradigm to Participate in TD Cowen Annual Health Care Conference
-
Veradigm Receives Expected Delisting Notice from Nasdaq
-
Veradigm Provides Update on its Financial Restatement Process
-
Veradigm to Acquire ScienceIO
-
Veradigm to Highlight New EHR-Integrated Care Gap Alert Solution at ViVE 2024 Conference
-
Veradigm Reveals New Insights on the Prevalence of Cardiovascular Conditions in the U.S.
-
Veradigm and American College of Cardiology Launch Influenza Vaccination Education Initiative to Improve Cardiovascular Health
-
VERADIGM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus
-
MONDAY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Veradigm, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - MDRX
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, Microvast, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors with to Secure Counsel Before Important January 22 Deadline in Securities Class Action �
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
-
Omnicell Elects Eileen Voynick to Board of Directors
-
VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus
-
New Veradigm Leadership Provides Outlook on Business and Strategy, and Refreshed Financial Estimates for Fiscal 2023
-
Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Veradigm, Fisker, and Eagle Pharmaceuticals and Encourages Investors to Contact the Firm
-
Berman Tabacco Announces Investigation of Veradigm Inc. (MDRX) for Potential Securities Law Violations
-
VERADIGM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly
-
Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Holley, Veradigm, and Fisker and Encourages Investors to Contact the Firm
-
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit - MDRX
-
Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company
-
ROSEN, A LONGSTANDING LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Holley, Veradigm, and Fisker and Encourages Investors to Contact the Firm
-
VERADIGM SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Discus
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDR
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
VERADIGM ONGOING DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly To Di
-
MDRX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Veradigm Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
Lowey Dannenberg Notifies Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to
-
VERADIGM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directly
-
Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing Requirements
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
Lowey Dannenberg Notifies Veradigm Inc. (“Veradigm” or the “Company”) (NASDAQ: MDRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to
-
Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing Services
-
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MDRX
-
Veradigm Inc. Announces Leadership Transition
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
-
VERADIGM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Veradigm To Contact Him Directl
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Veradigm Inc. and Encourages Investors to Contact the Firm
Back to MDRX Stock Lookup
